Cargando…

First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY

Background: The coronavirus disease 2019 (COVID-19) vaccination programme in England was extended to include all adolescents and children by April 2022. The aim of this paper is to describe trends and variation in vaccine coverage in different clinical and demographic groups amongst adolescents and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopcroft, Lisa E., Curtis, Helen J., Brown, Andrew D., Hulme, William J., Andrews, Colm D., Morton, Caroline E., Inglesby, Peter, Morley, Jessica, Mehrkar, Amir, Bacon, Sebastian C., Eggo, Rosalind M., Mahalingasivam, Viyaasan, Parker, Edward P. K., Tomlinson, Laurie A., Bates, Christopher, Cockburn, Jonathan, Parry, John, Hester, Frank, Harper, Sam, Goldacre, Ben, Walker, Alex J., MacKenna, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280033/
https://www.ncbi.nlm.nih.gov/pubmed/37346822
http://dx.doi.org/10.12688/wellcomeopenres.18735.2
_version_ 1785060718048968704
author Hopcroft, Lisa E.
Curtis, Helen J.
Brown, Andrew D.
Hulme, William J.
Andrews, Colm D.
Morton, Caroline E.
Inglesby, Peter
Morley, Jessica
Mehrkar, Amir
Bacon, Sebastian C.
Eggo, Rosalind M.
Mahalingasivam, Viyaasan
Parker, Edward P. K.
Tomlinson, Laurie A.
Bates, Christopher
Cockburn, Jonathan
Parry, John
Hester, Frank
Harper, Sam
Goldacre, Ben
Walker, Alex J.
MacKenna, Brian
author_facet Hopcroft, Lisa E.
Curtis, Helen J.
Brown, Andrew D.
Hulme, William J.
Andrews, Colm D.
Morton, Caroline E.
Inglesby, Peter
Morley, Jessica
Mehrkar, Amir
Bacon, Sebastian C.
Eggo, Rosalind M.
Mahalingasivam, Viyaasan
Parker, Edward P. K.
Tomlinson, Laurie A.
Bates, Christopher
Cockburn, Jonathan
Parry, John
Hester, Frank
Harper, Sam
Goldacre, Ben
Walker, Alex J.
MacKenna, Brian
author_sort Hopcroft, Lisa E.
collection PubMed
description Background: The coronavirus disease 2019 (COVID-19) vaccination programme in England was extended to include all adolescents and children by April 2022. The aim of this paper is to describe trends and variation in vaccine coverage in different clinical and demographic groups amongst adolescents and children in England by August 2022. Methods: With the approval of NHS England, a cohort study was conducted of 3.21 million children and adolescents’ records in general practice in England,  in situ and within the infrastructure of the electronic health record software vendor TPP using OpenSAFELY. Vaccine coverage across various demographic (sex, deprivation index and ethnicity) and clinical (risk status) populations is described. Results: Coverage is higher amongst adolescents than it is amongst children, with 53.5% adolescents and 10.8% children having received their first dose of the COVID-19 vaccine. Within those groups, coverage varies by ethnicity, deprivation index and risk status; there is no evidence of variation by sex. Conclusion: First dose COVID-19 vaccine coverage is shown to vary amongst various demographic and clinical groups of children and adolescents.
format Online
Article
Text
id pubmed-10280033
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-102800332023-06-21 First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY Hopcroft, Lisa E. Curtis, Helen J. Brown, Andrew D. Hulme, William J. Andrews, Colm D. Morton, Caroline E. Inglesby, Peter Morley, Jessica Mehrkar, Amir Bacon, Sebastian C. Eggo, Rosalind M. Mahalingasivam, Viyaasan Parker, Edward P. K. Tomlinson, Laurie A. Bates, Christopher Cockburn, Jonathan Parry, John Hester, Frank Harper, Sam Goldacre, Ben Walker, Alex J. MacKenna, Brian Wellcome Open Res Research Note Background: The coronavirus disease 2019 (COVID-19) vaccination programme in England was extended to include all adolescents and children by April 2022. The aim of this paper is to describe trends and variation in vaccine coverage in different clinical and demographic groups amongst adolescents and children in England by August 2022. Methods: With the approval of NHS England, a cohort study was conducted of 3.21 million children and adolescents’ records in general practice in England,  in situ and within the infrastructure of the electronic health record software vendor TPP using OpenSAFELY. Vaccine coverage across various demographic (sex, deprivation index and ethnicity) and clinical (risk status) populations is described. Results: Coverage is higher amongst adolescents than it is amongst children, with 53.5% adolescents and 10.8% children having received their first dose of the COVID-19 vaccine. Within those groups, coverage varies by ethnicity, deprivation index and risk status; there is no evidence of variation by sex. Conclusion: First dose COVID-19 vaccine coverage is shown to vary amongst various demographic and clinical groups of children and adolescents. F1000 Research Limited 2023-06-09 /pmc/articles/PMC10280033/ /pubmed/37346822 http://dx.doi.org/10.12688/wellcomeopenres.18735.2 Text en Copyright: © 2023 Hopcroft LE et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Note
Hopcroft, Lisa E.
Curtis, Helen J.
Brown, Andrew D.
Hulme, William J.
Andrews, Colm D.
Morton, Caroline E.
Inglesby, Peter
Morley, Jessica
Mehrkar, Amir
Bacon, Sebastian C.
Eggo, Rosalind M.
Mahalingasivam, Viyaasan
Parker, Edward P. K.
Tomlinson, Laurie A.
Bates, Christopher
Cockburn, Jonathan
Parry, John
Hester, Frank
Harper, Sam
Goldacre, Ben
Walker, Alex J.
MacKenna, Brian
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
title First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
title_full First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
title_fullStr First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
title_full_unstemmed First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
title_short First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
title_sort first dose covid-19 vaccine coverage amongst adolescents and children in england: an analysis of 3.21 million patients' primary care records in situ using opensafely
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280033/
https://www.ncbi.nlm.nih.gov/pubmed/37346822
http://dx.doi.org/10.12688/wellcomeopenres.18735.2
work_keys_str_mv AT hopcroftlisae firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT curtishelenj firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT brownandrewd firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT hulmewilliamj firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT andrewscolmd firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT mortoncarolinee firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT inglesbypeter firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT morleyjessica firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT mehrkaramir firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT baconsebastianc firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT eggorosalindm firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT mahalingasivamviyaasan firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT parkeredwardpk firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT tomlinsonlauriea firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT bateschristopher firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT cockburnjonathan firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT parryjohn firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT hesterfrank firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT harpersam firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT goldacreben firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT walkeralexj firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely
AT mackennabrian firstdosecovid19vaccinecoverageamongstadolescentsandchildreninenglandananalysisof321millionpatientsprimarycarerecordsinsituusingopensafely